Gergen Mark J Insider Trades

Insider Trading History

Track insider trading activity for Gergen Mark J. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Poseida Therapeutics
Poseida Therapeutics PSTX
President And CEO
Holding Value $0 0 shares
Last Trade
Jan 08, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$16.7M 1,760,996 shares
$9.50
$9.50
Poseida Therapeutics
Poseida Therapeutics PSTX
President And CEO
Holding Value $0 0 shares
Last Trade
Jan 08, 2025 Sale (Tender)Reported as Tender on SEC Form 4.
$5.73M 636,726 shares
$9.00
$9.50
Poseida Therapeutics
Poseida Therapeutics PSTX
Executive Chairman
Holding Value $5.99M 630,726 shares
Last Trade
Jan 02, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$224k 23,313 shares
$9.60
$9.50
Poseida Therapeutics
Poseida Therapeutics PSTX
Executive Chairman
Holding Value $6.19M 651,291 shares
Last Trade
Dec 10, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$284k 30,000 shares
$9.46
$9.50
Poseida Therapeutics
Poseida Therapeutics PSTX
Executive Chairman
Holding Value $916k 96,372 shares
Last Trade
Dec 10, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$284k 30,000 shares
$9.45
$9.50
Poseida Therapeutics
Poseida Therapeutics PSTX
Executive Chairman
Holding Value $6.47M 681,291 shares
Last Trade
Dec 10, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$284k 30,000 shares
$9.45
$9.50
Poseida Therapeutics
Poseida Therapeutics PSTX
Executive Chairman
Holding Value $6.47M 681,291 shares
Last Trade
Nov 26, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$281k 30,000 shares
$9.38
$9.50
Poseida Therapeutics
Poseida Therapeutics PSTX
Executive Chairman
Holding Value $1.2M 126,372 shares
Last Trade
Nov 26, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$281k 30,000 shares
$9.38
$9.50
Poseida Therapeutics
Poseida Therapeutics PSTX
Executive Chairman
Holding Value $6.19M 651,291 shares
Last Trade
Nov 26, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$278k 30,000 shares
$9.27
$9.50
Poseida Therapeutics
Poseida Therapeutics PSTX
Executive Chairman
Holding Value $6.19M 651,291 shares
Last Trade
Mar 01, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$141k 34,157 shares
$4.13
$9.50
Poseida Therapeutics
Poseida Therapeutics PSTX
Executive Chairman
Holding Value $6.51M 685,448 shares
Last Trade
Feb 01, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$161k 47,162 shares
$3.41
$9.50
Poseida Therapeutics
Poseida Therapeutics PSTX
Executive Chairman
Holding Value $6.96M 732,610 shares
Last Trade
Jan 02, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$583k 172,600 shares
$3.38
$9.50
Poseida Therapeutics
Poseida Therapeutics PSTX
President And CEO
Holding Value $5.72M 601,610 shares
Last Trade
Mar 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.95M 364,060 shares
$5.35
$9.50
Poseida Therapeutics
Poseida Therapeutics PSTX
President And CEO
Holding Value $3.14M 330,314 shares
Last Trade
Feb 01, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$223k 31,819 shares
$7.00
$9.50
Poseida Therapeutics
Poseida Therapeutics PSTX
President And CEO
Holding Value $4.93M 518,500 shares
Last Trade
Feb 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.46M 518,500 shares
$4.75
$9.50
Poseida Therapeutics
Poseida Therapeutics PSTX
President And CBO
Holding Value $3.25M 342,000 shares
Last Trade
Feb 04, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.13M 342,000 shares
$9.15
$9.50
Poseida Therapeutics
Poseida Therapeutics PSTX
President And CBO
Holding Value $713k 75,000 shares
Last Trade
Jul 09, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$9.50
Poseida Therapeutics
Poseida Therapeutics PSTX
President And CBO
Holding Value $0 0 shares
Last Trade
Jul 09, 2020 Sale
No data
No data
$9.50
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, Chief Operating Officer
Holding Value $5.22M 72,925 shares
Last Trade
Feb 22, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.43M 118,493 shares
$12.07
$71.60
Halozyme Therapeutics
Halozyme Therapeutics HALO
Svp, Chief Operating Officer
Holding Value $23.9M 333,890 shares
Last Trade
Sep 01, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.33M 333,890 shares
$9.97
$71.60

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up